Scholarlink

Background and Purpose <p>For patients with aggressive gastrointestinal malignancies, cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) offers a chance for prolonged survival but comes with risks of morbidity, decreased quality of life, and—rarely—death. Decision-making for patients considering CRS/HIPEC is complex and understudied. This study explored how patients approached the decision to pursue CRS/HIPEC and how they perceived their decisions postoperatively.</p> Methods <p>We performed a qualitative study with patients who underwent CRS/HIPEC between May 2023 and March 2024. Patients were interviewed using a semi-structured interview guide focused on understanding the decision-making process around CRS/HIPEC and assessing whether patients experienced decision regret after surgery. Transcripts were analyzed inductively using the constant comparative method.</p> Results <p>In total, 14 of 18 patients completed interviews at a median of 16.9 months after CRS/HIPEC (median age 57&#xa0;years; 50% women). We identified four key themes, which focused on patient sources of information about CRS/HIPEC, preoperative conversations about CRS/HIPEC, the decision-making-process, and decision satisfaction versus decision regret. Most patients felt they had little agency in the decision to pursue CRS/HIPEC but were trusting of their providers’ recommendations. Decision regret was uncommon and most associated with recurrent disease when present. Patients placed high value on their disease-free interval and time away from chemotherapy.</p> Discussion <p>This study offers an improved understanding of the decision-making process for patients pursuing CRS/HIPEC. Surgeons can use these data to improve preoperative counselling. Future quality-of-life studies should include questions to determine the value of chemotherapy-free intervals.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Decision-Making and Decision Satisfaction Following Cytoreductive Surgery and HIPEC for GI Malignancies: A Qualitative Study

  • 期刊论文

  • 发表日期：

    2026年5月11日

查看全文
  • Josh Bleicher,
  • Stephanie Jiang,
  • Sophia Aksenchuk,
  • Andrea McCart,
  • Danielle Bischof,
  • Andrea Covelli,
  • Anand Govindarajan

摘要

Background and Purpose

For patients with aggressive gastrointestinal malignancies, cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) offers a chance for prolonged survival but comes with risks of morbidity, decreased quality of life, and—rarely—death. Decision-making for patients considering CRS/HIPEC is complex and understudied. This study explored how patients approached the decision to pursue CRS/HIPEC and how they perceived their decisions postoperatively.

Methods

We performed a qualitative study with patients who underwent CRS/HIPEC between May 2023 and March 2024. Patients were interviewed using a semi-structured interview guide focused on understanding the decision-making process around CRS/HIPEC and assessing whether patients experienced decision regret after surgery. Transcripts were analyzed inductively using the constant comparative method.

Results

In total, 14 of 18 patients completed interviews at a median of 16.9 months after CRS/HIPEC (median age 57 years; 50% women). We identified four key themes, which focused on patient sources of information about CRS/HIPEC, preoperative conversations about CRS/HIPEC, the decision-making-process, and decision satisfaction versus decision regret. Most patients felt they had little agency in the decision to pursue CRS/HIPEC but were trusting of their providers’ recommendations. Decision regret was uncommon and most associated with recurrent disease when present. Patients placed high value on their disease-free interval and time away from chemotherapy.

Discussion

This study offers an improved understanding of the decision-making process for patients pursuing CRS/HIPEC. Surgeons can use these data to improve preoperative counselling. Future quality-of-life studies should include questions to determine the value of chemotherapy-free intervals.